Post by TherapeutAix

When a virtual biotech asked us to stress-test a rare-disease fibrosis program, we dug into the target, the data, and the plan. Outcome: a clear view on target validity, a focused PK/PD & biomarker study plan (optionally operationalized via our CRO network), and proposals for clinical positioning that significantly increased interest from potential big-pharma investors. 👉 Read the case study here: https://lnkd.in/eUV8gUyg If you’re preparing an asset for IND or re-positioning in fibrosis, let’s talk. #DrugDevelopment #Fibrosis #TranslationalResearch #Biotech #CRO